CVT 124

Known as: CVT-124 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2010
012319982010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C. Short-term clinical effects of tolvaptan, an oral vasopressin… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Adenosine may adversely affect renal function via its effects on renal arterioles and tubuloglomerular feedback, but… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2002
2002
VARIATIONS OF NaCl concentration in the macula densa region of the tubule between 20 and 60 mM/l cause inverse changes in… (More)
Is this relevant?
2002
2002
To develop a novel route for the scaleable synthesis of the chiral xanthine CVT-124 (1, aka. BG9719), a method for the late stage… (More)
Is this relevant?
2001
2001
Our goal was to test the hypothesis that A(1) receptor blockade induces diuresis/natriuresis with a favorable renal hemodynamic… (More)
  • figure 1
  • figure 3
  • figure 5
  • figure 6
  • table 1
Is this relevant?
Review
2001
Review
2001
Renal function is a very important prognostic indicator in patients with congestive heart failure. While some of the prognostic… (More)
Is this relevant?
2000
2000
OBJECTIVES To determine the effects of furosemide and the selective A1 adenosine receptor BG9719 on renal function in patients… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
The natriuretic and diuretic action of a highly selective adenosine A1 receptor (A1AdoR) antagonist, 1,3-dipropyl-8-[2-(5,6-epoxy… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
1998
1998
Administration of the selective adenosine A1 receptor antagonist, CVT-124, to conscious chronically instrumented rats resulted in… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?